TenderDekho Logo
GEM

Contract Bidding Open For Amiodarone HCL 150mg, 3ml Inj,Metoprolol 1mg 1ml 5ml Inj,Nifedipine Retard 20mg Cap Tab,Propranolol in CENTRAL DELHI, DELHI

Bid Publish Date

27-May-2025, 5:06 pm

Bid End Date

26-Jun-2025, 6:00 pm

Value

₹28,054

Progress

Issue27-May-2025, 5:06 pm
Technical06-Aug-2025, 12:57 pm
AwardPending
Explore all 5 tabs to view complete tender details

Quantity

53796

Bid Type

Two Packet Bid

Categories 8

Indian Army invites bids for Amiodarone HCL 150mg, 3ml Inj, Metoprolol 1mg 1ml 5ml Inj, Nifedipine Retard 20mg Cap Tab, Propranolol TR 40mg tab, Digoxin 0. 25mg tab, Amlodipine Besylate 5mg tab, Atenolol 50mg plus Amlodipine 5mg tab, Losartan 50mg tab, Prazosin 5mg sustained release slow release tab, Enalapril 5mg tab, Bisoprolol 5mg tab, Amlodipine 10mg tab, Nicorandil 5mg tab, Tacrolimus Oint 0. 03 percent 20mg tube, Clindamycin phosphate 1percent topical gel tube of 10gm in CENTRAL DELHI, DELHI. Quantity: 53796. Submission Deadline: 26-06-2025 18: 00: 00. Submit your proposal before the deadline.

Additional Tender Data

Commercial Details

Tender Category

Goods

Bid To RA

No

Bid To RA Enabled

No

Item Category

Amiodarone HCL 150mg, 3ml Inj , Metoprolol 1mg 1ml 5ml Inj , Nifedipine Retard 20mg Cap Tab , Propranolol TR 40mg tab , Digoxin 0.25mg tab , Amlodipine Besylate 5mg tab , Atenolol 50mg plus Amlodipine 5mg tab , Losartan 50mg tab , Prazosin 5mg sustained release slow release tab , Enalapril 5mg tab , Bisoprolol 5mg tab , Amlodipine 10mg tab , Nicorandil 5mg tab , Tacrolimus Oint 0.03 percent 20mg tube , Clindamycin phosphate 1percent topical gel tube of 10gm

Authority Records

MINISTRY OF DEFENCEMILITARY AFFAIRS DEPARTMENTINDIAN ARMY

BID & GeM Expert Consultancy

End-to-end support — bid preparation, GeM registration, document filing & compliance by industry experts.

Bid Preparation GeM Registration Document Filing

Free consultation · 24h response

Documents 5

GeM-Bidding-7895261.pdf

Main Document

BOQ Document

BOQ

BOQ Document

BOQ

Buyer uploaded ATC document

ATC

GEM General Terms and Conditions Document

GEM_GENERAL_TERMS_AND_CONDITIONS

Bill of Quantities (BOQ) 15 Items Sign in for GEM prices

#1

Amiodarone HCL 150mg, 3ml Inj

Amiodarone HCL 150mg, 3ml Inj

12 amp Delivery: 15 days
#2

Metoprolol 1mg 1ml 5ml Inj

Metoprolol 1mg/1ml , 5ml Inj

12 amp Delivery: 15 days
#3

Nifedipine Retard 20mg Cap Tab

Nifedipine Retard 20mg Cap/Tab

600 no Delivery: 15 days
#4

Propranolol TR 40mg tab

Propranolol TR 40mg tab

2,100 no Delivery: 15 days
#5

Digoxin 0.25mg tab

Digoxin 0.25mg tab

600 no Delivery: 15 days
#6

Amlodipine Besylate 5mg tab

Amlodipine Besylate 5mg tab

30,000 no Delivery: 15 days
#7

Atenolol 50mg plus Amlodipine 5mg tab

Atenolol 50mg+Amlodipine 5mg tab

780 no Delivery: 15 days
#8

Losartan 50mg tab

Losartan 50mg tab

6,000 no Delivery: 15 days
#9

Prazosin 5mg sustained release slow release tab

Prazosin 5mg sustained release /slow release tab

3,300 no Delivery: 15 days
#10

Enalapril 5mg tab

Enalapril 5mg tab

1,500 no Delivery: 15 days
#11

Bisoprolol 5mg tab

Bisoprolol 5mg tab

600 no Delivery: 15 days
#12

Amlodipine 10mg tab

Amlodipine 10mg tab

6,000 no Delivery: 15 days
#13

Nicorandil 5mg tab

Nicorandil 5mg tab

1,500 tube Delivery: 15 days
#14

Tacrolimus Oint 0.03 percent 20mg tube

Tacrolimus Oint 0.03% 20mg tube

72 tube Delivery: 15 days
#15

Clindamycin phosphate 1percent topical gel tube of 10gm

Clindamycin phosphate 1% topical gel tube of 10gm

720 tube Delivery: 16 days

Required Documents

1

Experience Criteria

2

Past Performance

3

Bidder Turnover

4

Certificate (Requested in ATC)

5

OEM Authorization Certificate

6

OEM Annual Turnover

7

Additional Doc 1 (Requested in ATC)

8

Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria

9

the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer

Technical Results

S.No Seller Item Date Status
1
chemo biological   Under PMA
-08-06-2025 12:57:11
2
FAIRDEAL HEALTH CARE PRIVATE LIMITED   Under PMA
-26-06-2025 16:24:08
3
NEW LIFE MEDICOS   Under PMA
-24-06-2025 16:09:12
4
PRAKASH MEDICOS   Under PMA
-25-06-2025 12:53:40
5
PUSHYA MEDISURG   Under PMA
-21-06-2025 16:50:27
6
SHRISHTI PHARMACEUTICAL & SURGICALS   Under PMA
-23-06-2025 16:45:03
7
SRI G PHARMACEUTICALS   Under PMA
-02-06-2025 13:13:04
8
SRI SAI AGENCIES   Under PMA
-20-06-2025 10:10:29
9
SUKUN PHARMA   Under PMA
-11-06-2025 13:23:04

Frequently Asked Questions

Key insights about DELHI tender market

What are the eligibility requirements for participating in the tender?

The eligibility requirements include being a registered entity under the relevant pharmaceutical regulations, possessing the necessary licenses, and demonstrating prior experience in supplying to government sectors. It’s essential for bidders to provide certifications that verify compliance with quality and safety standards relevant to the pharmaceutical industry.

What certificates are required to submit a bid?

Bidders must provide valid certifications confirming compliance with Good Manufacturing Practices (GMP), along with other necessary licenses pertaining to pharmaceutical products. Additionally, proof of previous successful supply contracts or references from satisfied clients may enhance the bid's credibility.

How do I register to participate in the tender process?

To register for the tender, bidders must visit the official government procurement portal and complete the registration procedure as outlined. The registration involves submitting your entity details, necessary compliance documents, and agreeing to the terms set forth for the bidding.

What formats are accepted for document submissions?

All documentation must be uploaded in PDF format on the government procurement portal. It's crucial that all documents are legible and accurately represent the required information as specified in the tender documentation guidelines.

What is the procedure for bid evaluation and notification of results?

Bids will undergo a dual-phase evaluation process where technical compliance will be reviewed first, followed by financial bidding. Bidders will be notified of the results through official communications via the procurement portal, alongside detailed insights into the evaluation outcomes.